0001209191-22-058095.txt : 20221121 0001209191-22-058095.hdr.sgml : 20221121 20221121160814 ACCESSION NUMBER: 0001209191-22-058095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221117 FILED AS OF DATE: 20221121 DATE AS OF CHANGE: 20221121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curley Joanne CENTRAL INDEX KEY: 0001857670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 221405822 MAIL ADDRESS: STREET 1: C/O VISTAGEN THERAPEUTICS, INC. STREET 2: 343 ALLERTON AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-17 0 0001831828 Vera Therapeutics, Inc. VERA 0001857670 Curley Joanne C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 0 1 0 0 Chief Development Officer Class A Common Stock 2022-11-17 4 M 0 1078 6.3728 A 28393 D Class A Common Stock 2022-11-17 4 S 0 1078 15.8606 D 27315 D Class A Common Stock 2022-11-17 4 M 0 2211 2.8968 A 29526 D Class A Common Stock 2022-11-17 4 S 0 2211 15.8436 D 27315 D Stock Option (right to buy) 6.3728 2022-11-17 4 M 0 1078 0.00 D 2030-03-31 Class A Common Stock 1078 9717 D Stock Option (right to buy) 2.8968 2022-11-17 4 M 0 2211 0.00 D 2030-12-15 Class A Common Stock 2211 38013 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.45 to $16.13, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $16.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter. 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter. /s/ Joseph R. Young, Attorney-in-Fact 2022-11-21